Research Article

Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer

Table 5

Correlation between clinical pathology and neoadjuvant efficacy before neoadjuvant therapy (baseline).

Spearman’s rhoPR/SDPR/SD + PD

Age (≤60/>60)N = 27r0.0690.098
p0.7340.635

T Stage (≤3/>3)N = 27r0.2170.184
p0.2770.367

N stageN = 23r0.1740.157
p0.4280.486

CA19-9 (normal/abnormal)N = 27r0.1740.157
p0.4280.486

When (two-tailed) or (two-tailed), it indicated a significant correlation. CTC, circulating tumor cell; PR, partial response; SD, stable disease; PD, progressive disease; and N, case number.